NCT05334940 Atopy Network - Comprehensive Allergy Centers: Medical Care of Patients With Moderate to Severe Allergic Diseases
| NCT ID | NCT05334940 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Charite University, Berlin, Germany |
| Condition | Atopic Disorders |
| Study Type | OBSERVATIONAL |
| Enrollment | 600 participants |
| Start Date | 2022-12-08 |
| Primary Completion | 2025-08-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 600 participants in total. It began in 2022-12-08 with a primary completion date of 2025-08-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The Atopy Registry aims to assess data about atopic disorders and their medical care in a standardized form. With this, the comparative efficacy, tolerability and safety of systemic therapies for atopic disorders should be investigated. An optional additional module "Bioanalytic" shall provide insights into further connections regarding immunology, genetics and microbiome.
Eligibility Criteria
Inclusion Criteria: * patients are at least 6 years old * patients with a proven moderate to severe atopic disorder who are planned to receive a biologic systemic therapy * at least one additional proven atopic disorder Exclusion Criteria: * \<2 atopic disorders * poor compliance * pregnancy or breastfeeding
Contact & Investigator
Margitta Worm, Prof.
STUDY CHAIR
Charite University, Berlin, Germany
Frequently Asked Questions
Who can join the NCT05334940 clinical trial?
This trial is open to participants of all sexes, aged 6 Years or older, studying Atopic Disorders. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05334940 currently recruiting?
Yes, NCT05334940 is actively recruiting participants. Contact the research team at margitta.worm@charite.de for enrollment information.
Where is the NCT05334940 trial being conducted?
This trial is being conducted at Berlin, Germany.
Who is sponsoring the NCT05334940 clinical trial?
NCT05334940 is sponsored by Charite University, Berlin, Germany. The principal investigator is Margitta Worm, Prof. at Charite University, Berlin, Germany. The trial plans to enroll 600 participants.